Table 3:

The distribution of the probability of being late across disease working group ordered by mean.

Disease Working Group	Count	Mean ($P_{Late}$)	SD ($P_{Late}$)
Brain	4	56.37%	0.4060
Sarcoma/Melanoma	6	57.16%	0.3948
Multiple	19	57.85%	0.1083
Leukemia/Myeloid	24	63.52%	0.3378
Breast	13	64.20%	0.3747
Lymphoma/Myeloma	12	69.12%	0.2609
Lung	11	69.33%	0.2585
Gynecology	5	70.71%	0.2302
Gastrointestinal	9	70.85%	0.2627
Genitourinary	10	79.78%	0.2767
Head and Neck	2	86.01%	0.1399
Multiple Early Phase Clinical Trials	4	90.53%	0.1577